Literature DB >> 10408858

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.

A A van Tilborg, L E Groenfeld, T H van der Kwast, E C Zwarthoff.   

Abstract

The most frequent genetic alterations in transitional cell carcinoma (TCC) of the bladder involve loss of heterozygosity (LOH) on chromosome 9p and 9q. The LOH on chromosome 9p most likely targets the CDKN2 locus, which is inactivated in about 50% of TCCs. Candidate genes that are the target for LOH on chromosome 9q have yet to be identified. To narrow the localization of one or more putative tumour suppressor genes on this chromosome that play a role in TCC of the bladder, we examined 59 tumours with a panel of microsatellite markers along the chromosome. LOH was observed in 26 (44%) tumours. We present evidence for two different loci on the long arm of chromosome 9 where potential tumour suppressor genes are expected. These loci are delineated by interstitial deletions in two bladder tumours. Our results confirm the results of others and contribute to a further reduction of the size of these regions, which we called TCC1 and TCC2. These regions were examined for homozygous deletions with EST and STS markers. No homozygous deletions were observed in 17 different bladder tumour cell lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408858      PMCID: PMC2362340          DOI: 10.1038/sj.bjc.6690383

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.

Authors:  I Orlow; P Lianes; L Lacombe; G Dalbagni; V E Reuter; C Cordon-Cardo
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

2.  Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.

Authors:  R Shipman; P Schraml; M Colombi; G Raefle; C U Ludwig
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

3.  Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.

Authors:  A J Keen; M A Knowles
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

4.  Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer.

Authors:  A Merlo; E Gabrielson; M Mabry; R Vollmer; S B Baylin; D Sidransky
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

5.  Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

Authors:  P Cairns; M E Shaw; M A Knowles
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

6.  Evidence for two bladder cancer suppressor loci on human chromosome 9.

Authors:  J M Ruppert; K Tokino; D Sidransky
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750kB region at 4p16.3.

Authors:  P A Elder; S M Bell; M A Knowles
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

8.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

9.  An allelotype of squamous carcinoma of the head and neck using microsatellite markers.

Authors:  K W Ah-See; T G Cooke; I R Pickford; D Soutar; A Balmain
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay.

Authors:  A J Linnenbach; L B Pressler; B A Seng; B S Kimmel; J E Tomaszewski; S B Malkowicz
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

View more
  4 in total

1.  Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.

Authors:  F Kimura; A R Florl; H H Seifert; J Louhelainen; S Maas; M A Knowles; W A Schulz
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

Review 2.  Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Authors:  Margaret A Knowles; Fiona M Platt; Rebecca L Ross; Carolyn D Hurst
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

3.  The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer.

Authors:  Achim Weber; Ilka Kristiansen; Manfred Johannsen; Beibei Oelrich; Katharina Scholmann; Sven Gunia; Matthias May; Hellmuth-Alexander Meyer; Silvia Behnke; Holger Moch; Glen Kristiansen
Journal:  BMC Cancer       Date:  2008-12-16       Impact factor: 4.430

4.  Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Authors:  Louis S Pymar; Fiona M Platt; Jon M Askham; Ewan E Morrison; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.